NVO inks deal with OpenAI for speedy drug discovery globally
Digest more
AWS's new AI platform grants researchers direct access to a broad library of biological foundation models for lab-in-the-loop drug discovery.
In December, The Conversation hosted a webinar on AI's revolutionary role in drug discovery and development. Science and ...
Since 2008, Labroots has used its virtual events to connect a global network of scientists regarding the latest advancements in their fields. These virtual events include structured poster discussion ...
AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma. Biotech uses AI for breakthrough discovery, while large pharma scales it to ...
In modern drug discovery, successfully navigating the progress from molecular concept to viable therapeutic often hinges on ...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 10th Annual Drug Discovery & Development Virtual Event on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results